Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 8/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5698940 | 0.85 | MEN1 (0.52) | MEN1KMT2AKDM4EABCB1CYP2D6 | |
| SCHEMBL7526130 | 0.81 | ABCB1 (0.49) | MEN1KMT2AKDM4EABCB1CYP2D6 | |
| SCHEMBL7530991 | 0.80 | ABCB1 (0.48) | MEN1KMT2AKDM4EABCB1CYP2D6 | |
| SCHEMBL6631200 | 0.79 | ABCB1 (0.44) | MEN1KMT2AKDM4EABCB1CYP2D6 | |
| SCHEMBL3073558 | 0.78 | ABCB1 (0.60) | KDM4EABCB1CYP2D6TSHRHIF1A | |
| SCHEMBL3076619 | 0.77 | ALDH1A1 (0.48) | MEN1KMT2AKDM4EABCB1CYP2D6 | |
| Hydrochloric Acid SCHEMBL9329212 | 0.77 | ABCB1 (0.59) | KDM4EABCB1CYP2D6TSHRHIF1A | |
| Hydrochloric Acid SCHEMBL7226297 | 0.77 | ABCB1 (0.59) | KDM4EABCB1CYP2D6TSHRHIF1A | |
| SCHEMBL7523557 | 0.76 | POLB (0.55) | MEN1KMT2AKDM4EABCB1CYP2D6 | |
| Bromide SCHEMBL9327702 | 0.76 | ABCB1 (0.58) | KDM4EABCB1CYP2D6TSHRHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040053990-A1 | Radicicol derivatives | KYOWA HAKKO KOGYO CO., LTD (JP) | 2004-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040053990-A1 | Radicicol derivatives | ROS1, LYN, SRC | MEN1 3889/4885KMT2A 3585/4885KDM4E 1923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.